Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta
- 1 April 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (8) , 714-722
- https://doi.org/10.1038/sj.gt.3301149
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 39 references indexed in Scilit:
- LIGAND RECOGNITION BY αβ T CELL RECEPTORSAnnual Review of Immunology, 1998
- Gene Therapy for Rheumatoid ArthritisDrugs & Aging, 1998
- Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.Journal of Clinical Investigation, 1996
- Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13European Journal of Immunology, 1996
- Comparative Properties of the Single Chain Antibody and Fv Derivatives of mAb 4-4-20Published by Elsevier ,1996
- Macrophages, but not dendritic cells, present collagen to T cellsEuropean Journal of Immunology, 1995
- Published by American Association for the Advancement of Science (AAAS) ,1994
- New simplified molecular design for functional T cell receptorEuropean Journal of Immunology, 1993
- Sequence requirements for induction of cytolysis by the T cell antigenFc receptor ζ chainCell, 1992
- Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsinBiochemistry, 1972